CrystalsFirst’s unique MAGNET platform unlocks high-fidelity chemical matter across different drug targets and binding modalities. The company offers its high-performance screening, protein production, and structural biology platform to pharmaceutical and biotechnology companies for small molecule drug discovery.
Within the broad fields of structure-based drug discovery and fragment-based lead generation, the application of CrystalsFirst’s proprietary technology SmartSoak® provides rapid structural insights into numerous target interaction modes with atomic resolution. The company’s fast access to the highest resolution structural data and molecular design strategies support medicinal chemistry in the development of candidate molecules in a time- and cost-efficient way.
Within the broad fields of structure-based drug discovery and fragment-based lead generation, the application of CrystalsFirst’s proprietary technology SmartSoak® provides rapid structural insights into numerous target interaction modes with atomic resolution. The company’s fast access to the highest resolution structural data and molecular design strategies support medicinal chemistry in the development of candidate molecules in a time- and cost-efficient way.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
